ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $75,000 | -49.3% | 80,903 | +11.2% | 0.00% | – |
| Q4 2019 | $148,000 | -77.4% | 72,775 | -68.1% | 0.00% | -100.0% |
| Q3 2019 | $654,000 | -90.2% | 228,163 | -73.8% | 0.00% | -90.0% |
| Q2 2019 | $6,675,000 | -49.1% | 870,337 | -11.9% | 0.01% | -54.5% |
| Q1 2019 | $13,125,000 | +44.2% | 987,603 | +69.1% | 0.02% | +37.5% |
| Q4 2018 | $9,100,000 | +4.5% | 584,152 | +31.8% | 0.02% | +23.1% |
| Q3 2018 | $8,707,000 | +7.9% | 443,131 | +57.5% | 0.01% | +8.3% |
| Q2 2018 | $8,073,000 | +10.5% | 281,278 | -9.0% | 0.01% | +9.1% |
| Q1 2018 | $7,309,000 | +41.7% | 309,014 | +28.5% | 0.01% | +57.1% |
| Q4 2017 | $5,157,000 | +34.3% | 240,388 | +48.0% | 0.01% | +16.7% |
| Q3 2017 | $3,840,000 | +8.9% | 162,385 | -9.3% | 0.01% | +20.0% |
| Q2 2017 | $3,527,000 | -36.3% | 179,045 | -32.1% | 0.01% | -44.4% |
| Q1 2017 | $5,540,000 | +154.7% | 263,785 | +128.0% | 0.01% | +200.0% |
| Q4 2016 | $2,175,000 | +7.9% | 115,672 | +19.8% | 0.00% | 0.0% |
| Q3 2016 | $2,016,000 | -81.8% | 96,552 | -77.7% | 0.00% | -84.2% |
| Q2 2016 | $11,051,000 | +23.0% | 433,292 | +27.6% | 0.02% | +18.8% |
| Q1 2016 | $8,984,000 | +109.5% | 339,652 | +238.8% | 0.02% | +100.0% |
| Q4 2015 | $4,289,000 | +64.5% | 100,252 | +1.9% | 0.01% | +60.0% |
| Q3 2015 | $2,607,000 | -19.6% | 98,352 | +1.1% | 0.01% | -16.7% |
| Q2 2015 | $3,241,000 | -34.4% | 97,252 | -34.5% | 0.01% | -33.3% |
| Q1 2015 | $4,944,000 | -22.7% | 148,552 | -5.0% | 0.01% | -25.0% |
| Q4 2014 | $6,394,000 | +17.1% | 156,452 | -2.9% | 0.01% | +20.0% |
| Q3 2014 | $5,460,000 | -37.3% | 161,152 | -37.6% | 0.01% | -33.3% |
| Q2 2014 | $8,710,000 | -12.4% | 258,367 | -1.5% | 0.02% | -21.1% |
| Q1 2014 | $9,946,000 | +28.6% | 262,352 | -0.9% | 0.02% | +26.7% |
| Q4 2013 | $7,734,000 | -14.1% | 264,852 | +0.8% | 0.02% | -21.1% |
| Q3 2013 | $9,004,000 | +29.9% | 262,652 | +25.0% | 0.02% | +26.7% |
| Q2 2013 | $6,930,000 | – | 210,052 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|